How microrobots should be translated: A clinical and value‐centered readiness framework
Bioengineering & Translational Medicine · 2026-05 · 11 (3)
DOI: 10.1002/btm2.70112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 03.02.2026. Verfasst von Hakan Ceylan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Microrobots Lab, Department of Physiology and Biomedical Engineering Mayo Clinic Scottsdale Arizona USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Untethered mobile milli/microrobots hold transformative potential for interventional medicine by enabling more precise and entirely non‐invasive diagnosis and therapy. Realizing this promise requires bridging the gap between groundbreaking laboratory demonstrations and successful clinical integration. Despite remarkable technical progress over the past two decades, most millirobots and microrobots remain confined to laboratory proof‐of‐concept demonstrations, with limited real‐world feasibility. Here, we identify key factors that slow translation from bench to bedside, focusing on the disconnect between technical innovation and meaningful patient outcomes. We argue that the long‐term impact and sustainability of the field depend on aligning development with unmet clinical needs, demonstrating feasibility, value and integration potential into existing clinical workflows. To foster translational research of milli/microrobots, we introduce a strategic milli/microrobot Technology Readiness Level framework (mTRL), which maps system development from initial conceptualization to clinical adoption through clearly defined milestones and their associated stepwise activities. The mTRL model provides a structured gauge of technological maturity, a common language for multi‐disciplinary collaboration and actionable guidance to accelerate translational development toward new, safer and more efficient interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Microrobots Lab, Department of Physiology and Biomedical Engineering Mayo Clinic Scottsdale Arizona USA.
- Max Planck Queensland Centre Queensland University of Technology Brisbane Queensland Australia.
- Italian Institute of Technology Genoa Italy.
- Department of Radiology Mayo Clinic Rochester Minnesota USA.
- Department of Medicine Mayo Clinic Scottsdale Arizona USA.
- Faculty of Engineering, School of Mechanical, Medical and Process Engineering Queensland University of Technology Brisbane Queensland Australia.
ORCID-Profile: Hakan Ceylan, Sanjay Misra, Dietmar W Hutmacher
Förderung
- National Institutes of Health
Zitieren
APA
Ceylan, H., Sinibaldi, E., Misra, S., Pasricha, P. J., & Hutmacher, D. W. (2026). How microrobots should be translated: A clinical and value‐centered readiness framework. Bioengineering & Translational Medicine, 11(3). https://doi.org/10.1002/btm2.70112
Vancouver
Ceylan H, Sinibaldi E, Misra S, Pasricha PJ, Hutmacher DW. How microrobots should be translated: A clinical and value‐centered readiness framework. Bioengineering & Translational Medicine. 2026;11(3). doi:10.1002/btm2.70112
BibTeX
@article{Ceylan2026,
author = {Ceylan, Hakan and Sinibaldi, Edoardo and Misra, Sanjay and Pasricha, Pankaj J and Hutmacher, Dietmar W},
title = {How microrobots should be translated: A clinical and value‐centered readiness framework},
journal = {Bioengineering & Translational Medicine},
year = {2026},
volume = {11},
number = {3},
doi = {10.1002/btm2.70112}
}
EUVIMED